Zurn Elkay CIO Troutman sells $3.9m in ZWS stock

Zurn Elkay Water Solutions (ZWS) reported strong Q2 2025 results, surpassing EPS and revenue estimates ($0.42 vs. $0.36; $445M vs. $424.61M) driven by 8% organic sales growth, leading Mizuho to raise its price target to $43 while maintaining a Neutral rating. Despite this robust performance and a recent 17% share surge, the company's CIO sold 90,916 shares for $3.9 million at $43.01, near the 52-week high, with InvestingPro noting a P/E of 44 that suggests potential overvaluation.

Analysis

Zurn Elkay Water Solutions (ZWS) presents a mixed signal for investors, characterized by strong recent fundamental performance juxtaposed with potential valuation concerns and a significant insider sale. The company delivered a robust second quarter for 2025, beating consensus estimates with an EPS of $0.42 against a projected $0.36 and revenue of $445 million versus an expected $424.61 million. This performance was underpinned by an 8% organic sales growth and effective tariff mitigation strategies. Consequently, Mizuho raised its price target to $43, reflecting the strong results, though its maintained 'Neutral' rating suggests the stock is perceived as fairly valued at current levels. This view is reinforced by the stock's recent 17% weekly surge, pushing its price near the 52-week high of $44.98. However, an InvestingPro analysis highlights a high P/E ratio of 44, indicating potential overvaluation. The Chief Information Officer's sale of 90,916 shares for $3.9 million at $43.01, although part of an option exercise, is a notable event occurring at this peak valuation, potentially signaling an executive belief that near-term upside may be limited.

Key Decisions for Investors

• Given the stock's 17% recent rally and a P/E ratio of 44, investors should be cautious as the price is near Mizuho's 'Neutral' rated target of $43, suggesting it may be fully valued.
• The CIO's sale of shares near a 52-week high, while common for option exercises, could be interpreted as a signal of peak valuation, prompting existing holders to consider trimming positions to realize gains.
• Monitor future earnings reports closely to see if the 8% organic growth is sustainable beyond Q3, as continued performance will be necessary to justify the current premium valuation, especially after tariff-related pre-buying subsides.